非药物治疗心力衰竭新进展

Update on nonpharmacologic treatment for heart failure

心力衰竭是一个拥有3 800万患者的全球化难题,而且这个数字随着人口老龄化而增加。心力衰竭是65岁以上入院患者中最常见疾病,并多发于高收入国家。每年因心力衰竭而住院的患者高达100万。目前药物治疗是临床中治疗心力衰竭的最主要方式,但传统药物治疗效果有限。探求新的治疗方法成为基础和临床研究的焦点。

Heart failure is a global problem that occurs in 38 million patients worldwide, and the number is dramatically increasing in elderly society. Meanwhile, heart dysfunction is also the most common disease among hospitalized patients more than 65 years, especially in high-income countries. Approximately, one million patients are hospitalized because of heart failure in the world every year. Drug therapy is currently the most popular treatment for heart failure in clinic, however, the effects are limited. Therefore, exploring novel treatment strategies gradually becomes a focus not only in basic but also in clinical research.